The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial
Abstract
In controlled clinical trials there are usually several prognostic factors known or thought to influence the patient's ability to respond to treatment. Therefore, the method of sequential treatment assignment needs to be designed so that treatment balance is simultaneously achieved across all such patients factor. Traditional methods of restricted randomization such as "permuted blocks within strata" prove inadequate once the number of strata, or combinations of factor levels, approaches the sample size. A new general procedure for treatment assignment is described which concentrates on minimizing imbalance in the distributions of treatment numbers within the levels of each individual prognostic factor. The improved treatment balance obtained by this approach is explored using simulation for a simple model of a clinical trial. Further discussion centers on the selection, predictability and practicability of such a procedure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, although balance in sample size may be achieved with this method, groups may be generated that are rarely comparable in terms of certain covariates, which could introduce bias in the statistical analysis and reduce the power of the study. Consequently, sample size and covariates should had been balanced in this clinical research [70].”
From Early Occupational Therapy Intervention post-stroke (EOTIPS): A randomized controlled trial (2024) · cites this paper as [70]
In the citing paper
“were randomly allocated to receive empagliflozin (10 mg once daily) or matching placebo using minimized randomization with a 10% stochastic element.17”
From Empagliflozin in Patients with Chronic Kidney Disease (2023) · cites this paper as [17]
In the citing paper
“The minimization randomization method, which is a deterministic scheme for allocating treatment with the goal of balancing prognostic factors, was applied to ensure equal participant numbers in each treatment group over multiple strata (i.e., equal number of participants in each arm within a fixed block size of four).(41)”
Citations
Cites
Forcing a sequential experiment to be balanced
EFRON, B. (1971) · Biometrika · doi:10.1093/biomet/58.3.403 · Cited by 873
Flagged first, then by citations
Cited by
Sorted by citations
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Mitsudomi, T., Morita, S., Yatabe, Y., Negoro, S., Okamoto, I., Tsurutani, J., Seto, T., Satouchi, M., Tada, H., Hirashima, T., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70364-x · Cited by 4,090
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Stummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., & Reulen, H.-J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70665-9 · Cited by 3,423
Tournigand, C., André, T., Achille, E., Lledo, G., Flesh, M., Mery-Mignard, D., Quinaux, E., Couteau, C., Buyse, M., Ganem, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.113 · Cited by 2,915
Empagliflozin in Patients with Chronic Kidney Disease
The EMPA-KIDNEY Collaborative Group (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2204233 · Cited by 2,754
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479
Sjöström, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12012 · Cited by 1,835
Bolla, M., Collette, L., Blank, L., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09408-4 · Cited by 1,686
Eggermont, A. M. M., Chiarion-Sileni, V., Grob, J.-J., Dummer, R., Wolchok, J. D., Schmidt, H., Hamid, O., Robert, C., Ascierto, P. A., Richards, J. M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70122-1 · Cited by 1,262
Cappuzzo, F., Ciuleanu, T., Stelmakh, L., Cicenas, S., Szczésna, A., Juhász, E., Esteban, E., Molinier, O., Brugger, W., Melezínek, I., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70112-1 · Cited by 1,186
Bennouna, J., Sastre, J., Arnold, D., Österlund, P., Greil, R., Van Cutsem, E., von Moos, R., Viéitez, J. M., Bouché, O., Borg, C., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70477-1 · Cited by 1,166
Ciuleanu, T., Brodowicz, T., Zielinski, C., Kim, J. H., Krzakowski, M., Laack, E., Wu, Y.-L., Bover, I., Begbie, S., Tzekova, V., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61497-5 · Cited by 1,111
An overview of randomization techniques: An unbiased assessment of outcome in clinical research
Suresh, K. (2011) · Journal of Human Reproductive Sciences · doi:10.4103/0974-1208.82352 · Cited by 1,070
“) that could confound the data and may negatively influence the results of the clinical trial.[11] Pocock and Simon stressed the importance of controlling for these covariates because of serious consequences to the interpretation of the results.”
ResultRetractedGomez, D. R., Blumenschein, G. R., Lee, J. J., Hernandez, M., Ye, R., Camidge, D. R., Doebele, R. C., Skoulidis, F., Gaspar, L. E., Gibbons, D. L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30532-0 · Cited by 1,086
Effects of anacetrapib in patients with atherosclerotic vascular disease
The HPS3/TIMI55–REVEAL Collaborative Group (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706444 · Cited by 1,047
RETRACTED: Avacopan for the Treatment of ANCA-Associated Vasculitis
Jayne, D. R. W., Merkel, P. A., Schall, T. J., & Bekker, P. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2023386 · Cited by 1,021
RetractedHeilbronn, L. K., de Jonge, L., Frisard, M. I., DeLany, J. P., Larson-Meyer, D. E., Rood, J., Nguyen, T., Martin, C. K., Volaufova, J., Most, M. M., et al. (2006) · JAMA · doi:10.1001/jama.295.13.1539 · Cited by 969
Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Effects of Testosterone Treatment in Older Men
Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506119 · Cited by 890
Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
Eisenberger, M. A., Blumenstein, B. A., Crawford, E. D., Miller, G., McLeod, D. G., Loehrer, P. J., Wilding, G., Sears, K., Culkin, D. J., Thompson, I. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391504 · Cited by 859
Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827
D'Angelo, S. P., Mahoney, M. R., Van Tine, B. A., Atkins, J., Milhem, M. M., Jahagirdar, B. N., Antonescu, C. R., Horvath, E., Tap, W. D., Schwartz, G. K., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30006-8 · Cited by 759
In Pursuit of Balance: Randomization in Practice in Development Field Experiments
Bruhn, M., & McKenzie, D. (2009) · American Economic Journal: Applied Economics · doi:10.1257/app.1.4.200 · Cited by 788
Intensive supportive care plus immunosuppression in IgA nephropathy
Rauen, T., Eitner, F., Fitzner, C., Sommerer, C., Zeier, M., Otte, B., Panzer, U., Peters, H., Benck, U., Mertens, P. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415463 · Cited by 726
Koehler, F., Koehler, K., Deckwart, O., Prescher, S., Wegscheider, K., Kirwan, B.-A., Winkler, S., Vettorazzi, E., Bruch, L., Oeff, M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31880-4 · Cited by 739
Koehler, F., Winkler, S., Schieber, M., Sechtem, U., Stangl, K., Böhm, M., Boll, H., Baumann, G., Honold, M., Koehler, K., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.018473 · Cited by 716
Bayesian approaches to randomized trials
Spiegelhalter, D. J., Freedman, L. S., & Parmar, M. K. B. (1994) · Journal of the Royal Statistical Society. Series A (Statistics in Society) · doi:10.2307/2983527 · Cited by 720
The method of minimization for allocation to clinical trials
Scott, N. W., McPherson, G. C., Ramsay, C. R., & Campbell, M. K. (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00242-8 · Cited by 651
Stratified Randomization for Clinical Trials
Kernan, W. N., Viscoli, C. M., Makuch, R. W., Brass, L. M., & Horwitz, R. I. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00138-3 · Cited by 627
Paz-Ares, L. G., de Marinis, F., Dediu, M., Thomas, M., Pujol, J.-L., Bidoli, P., Molinier, O., Sahoo, T. P., Laack, E., Reck, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.1102 · Cited by 624
Paz-Ares, L., de Marinis, F., Dediu, M., Thomas, M., Pujol, J.-L., Bidoli, P., Molinier, O., Sahoo, T. P., Laack, E., Reck, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70063-3 · Cited by 610
Weight lifting in women with breast-cancer-related lymphedema
Schmitz, K. H., Ahmed, R. L., Troxel, A., Cheville, A., Smith, R., Lewis-Grant, L., Bryan, C. J., Williams-Smith, C. T., & Greene, Q. P. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810118 · Cited by 578
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group (2010) · The Lancet · doi:10.1016/s0140-6736(10)60310-8 · Cited by 558
Issues in Outcomes Research: An Overview of Randomization Techniques for Clinical Trials
Kang, M., Ragan, B. G., & Park, J.-H. (2008) · Journal of Athletic Training · doi:10.4085/1062-6050-43.2.215 · Cited by 555
Rozeman, E. A., Menzies, A. M., van Akkooi, A. C. J., Adhikari, C., Bierman, C., van de Wiel, B. A., Scolyer, R. A., Krijgsman, O., Sikorska, K., Eriksson, H., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30151-2 · Cited by 537
Barlogie, B., Kyle, R. A., Anderson, K. C., Greipp, P. R., Lazarus, H. M., Hurd, D. D., McCoy, J., Moore, D. F., Dakhil, S. R., Lanier, K. S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5807 · Cited by 495
Kahan, B. C., Jairath, V., Doré, C. J., & Morris, T. P. (2014) · Trials · doi:10.1186/1745-6215-15-139 · Cited by 497
Phase III Evaluation of Fluoxetine for Treatment of Hot Flashes
Loprinzi, C. L., Sloan, J. A., Perez, E. A., Quella, S. K., Stella, P. J., Mailliard, J. A., Halyard, M. Y., Pruthi, S., Novotny, P. J., & Rummans, T. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1578 · Cited by 473
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
Hyer, M. L., Milhollen, M. A., Ciavarri, J., Fleming, P., Traore, T., Sappal, D., Huck, J., Shi, J., Gavin, J., Brownell, J., et al. (2018) · Nature Medicine · doi:10.1038/nm.4474 · Cited by 447
Goldstein, J. N., Refaai, M. A., Milling, T. J., Lewis, B., Goldberg-Alberts, R., Hug, B. A., & Sarode, R. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61685-8 · Cited by 461
Weight Lifting for Women at Risk for Breast Cancer–Related Lymphedema: A Randomized Trial
Schmitz, K. H., Ahmed, R. L., Troxel, A. B., Cheville, A., Lewis-Grant, L., Smith, R., Bryan, C. J., Williams-Smith, C. T., & Chittams, J. (2010) · JAMA · doi:10.1001/jama.2010.1837 · Cited by 410
Neacsiu, A. D., Eberle, J. W., Kramer, R., Wiesmann, T., & Linehan, M. M. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.05.005 · Cited by 394
Ciuleanu, T., Stelmakh, L., Cicenas, S., Miliauskas, S., Grigorescu, A. C., Hillenbach, C., Johannsdottir, H. K., Klughammer, B., & Gonzalez, E. E. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70385-0 · Cited by 374
Rummans, T. A., Clark, M. M., Sloan, J. A., Frost, M. H., Bostwick, J. M., Atherton, P. J., Johnson, M. E., Gamble, G., Richardson, J., Brown, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.209 · Cited by 353
Snyder, P. J., Kopperdahl, D. L., Stephens-Shields, A. J., Ellenberg, S. S., Cauley, J. A., Ensrud, K. E., Lewis, C. E., Barrett-Connor, E., Schwartz, A. V., Lee, D. C., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9539 · Cited by 363
Trial of prazosin for post-traumatic stress disorder in military veterans
Raskind, M. A., Peskind, E. R., Chow, B., Harris, C., Davis-Karim, A., Holmes, H. A., Hart, K. L., McFall, M., Mellman, T. A., Reist, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1507598 · Cited by 342
Ramanathan, R. K., McDonough, S. L., Philip, P. A., Hingorani, S. R., Lacy, J., Kortmansky, J. S., Thumar, J., Chiorean, E. G., Shields, A. F., Behl, D., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01295 · Cited by 336
SHARP Collaborative Group (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.08.012 · Cited by 319
Ueki, K., Sasako, T., Okazaki, Y., Kato, M., Okahata, S., Katsuyama, H., Haraguchi, M., Morita, A., Ohashi, K., Hara, K., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30327-3 · Cited by 313
Amaria, R. N., Prieto, P. A., Tetzlaff, M. T., Reuben, A., Andrews, M. C., Ross, M. I., Glitza, I. C., Cormier, J., Hwu, W.-J., Tawbi, H. A., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30015-9 · Cited by 299
Bray, G. A., Smith, S. R., de Jonge, L., Xie, H., Rood, J., Martin, C. K., Most, M., Brock, C., Mancuso, S., & Redman, L. M. (2012) · JAMA · doi:10.1001/jama.2011.1918 · Cited by 285
Giaccone, G., Bazhenova, L. A., Nemunaitis, J., Tan, M., Juhász, E., Ramlau, R., van den Heuvel, M. M., Lal, R., Kloecker, G. H., Eaton, K. D., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.035 · Cited by 279
Randomization in clinical trials: Conclusions and recommendations
Lachin, J. M., Matts, J. P., & Wei, L. J. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90049-9 · Cited by 272
Hirschfeld, R. M. A., Keck, P. E., Kramer, M., Karcher, K., Canuso, C., Eerdekens, M., & Grossman, F. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1057 · Cited by 273
An application of an urn model to the design of sequential controlled clinical trials.
Wei, L. J. (1978) · Journal of the American Statistical Association · doi:10.1080/01621459.1978.10480054 · Cited by 271
Iyadurai, L., Blackwell, S. E., Meiser-Stedman, R., Watson, P. C., Bonsall, M. B., Geddes, J. R., Nobre, A. C., & Holmes, E. A. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.23 · Cited by 266
Effect of home testing of international normalized ratio on clinical events
Matchar, D. B., Jacobson, A., Dolor, R., Edson, R., Uyeda, L., Phibbs, C. S., Vertrees, J. E., Shih, M.-C., Holodniy, M., & Lavori, P. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002617 · Cited by 266
A Mind-Body Program for Older Adults With Chronic Low Back Pain: A Randomized Clinical Trial
Morone, N. E., Greco, C. M., Moore, C. G., Rollman, B. L., Lane, B., Morrow, L. A., Glynn, N. W., & Weiner, D. K. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.8033 · Cited by 258
Pilot Controlled Trial of Mindfulness Meditation and Education for Dementia Caregivers
Oken, B. S., Fonareva, I., Haas, M., Wahbeh, H., Lane, J. B., Zajdel, D., & Amen, A. (2010) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2009.0733 · Cited by 232
Resnick, S. M., Matsumoto, A. M., Stephens-Shields, A. J., Ellenberg, S. S., Gill, T. M., Shumaker, S. A., Pleasants, D. D., Barrett-Connor, E., Bhasin, S., Cauley, J. A., et al. (2017) · JAMA · doi:10.1001/jama.2016.21044 · Cited by 220
Canada, A. L., Neese, L. E., Sui, D., & Schover, L. R. (2005) · Cancer · doi:10.1002/cncr.21537 · Cited by 217
Effects of Probiotics on Cognitive Reactivity, Mood, and Sleep Quality
Marotta, A., Sarno, E., Del Casale, A., Pane, M., Mogna, L., Amoruso, A., Felis, G. E., & Fiorio, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00164 · Cited by 186
Mitchell, P. H., Veith, R. C., Becker, K. J., Buzaitis, A., Cain, K. C., Fruin, M., Tirschwell, D., & Teri, L. (2009) · Stroke · doi:10.1161/strokeaha.109.549808 · Cited by 177
Chung, V., McDonough, S., Philip, P. A., Cardin, D., Wang-Gillam, A., Hui, L., Tejani, M. A., Seery, T. E., Dy, I. A., Al Baghdadi, T., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5383 · Cited by 176
Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels
Cunningham, G. R., Stephens-Shields, A. J., Rosen, R. C., Wang, C., Bhasin, S., Matsumoto, A. M., Parsons, J. K., Gill, T. M., Molitch, M. E., Farrar, J. T., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1645 · Cited by 162
Hummel, S. B., van Lankveld, J. J. D. M., Oldenburg, H. S. A., Hahn, D. E. E., Kieffer, J. M., Gerritsma, M. A., Kuenen, M. A., Bijker, N., Borgstein, P. J., Heuff, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.6021 · Cited by 162
Lin, Y., Zhu, M., & Su, Z. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.07.011 · Cited by 152
Mostad, I. L., Bjerve, K. S., Bjorgaas, M. R., Lydersen, S., & Grill, V. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.3.540 · Cited by 152
The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview
McEntegart, D. J. (2003) · Drug Information Journal · doi:10.1177/009286150303700305 · Cited by 145
Ryan, D. H. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.508 · Cited by 143
Cheville, A. L., Moynihan, T., Herrin, J., Loprinzi, C., & Kroenke, K. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0011 · Cited by 143
Taylor, C. L. C., deMoor, C., Smith, M. A., Dunn, A. L., Basen-Engquist, K., Nielsen, I., Pettaway, C., Sellin, R., Massey, P., & Gritz, E. R. (2006) · Psycho-Oncology · doi:10.1002/pon.1023 · Cited by 140
The use of minimization in clinical trials
Taves, D. R. (2010) · Contemporary Clinical Trials · doi:10.1016/j.cct.2009.12.005 · Cited by 140
Controversies concerning randomization and additivity in clinical trials.
Senn, S. (2004) · Statistics in Medicine · doi:10.1002/sim.2074 · Cited by 132
A roadmap to using randomization in clinical trials
Berger, V. W., Bour, L. J., Carter, K., Chipman, J. J., Everett, C. C., Heussen, N., Hewitt, C., Hilgers, R.-D., Luo, Y. A., Renteria, J., et al. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01303-z · Cited by 135
Ma, J., Rosas, L. G., Lv, N., Xiao, L., Snowden, M. B., Venditti, E. M., Lewis, M. A., Goldhaber-Fiebert, J. D., & Lavori, P. W. (2019) · JAMA · doi:10.1001/jama.2019.0557 · Cited by 133
Kable, J. W., Caulfield, M. K., Falcone, M., McConnell, M., Bernardo, L., Parthasarathi, T., Cooper, N., Ashare, R., Audrain-McGovern, J., Hornik, R., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2832-16.2017 · Cited by 124
Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer.
TORMEY, D. C., LIPPMAN, M. E., EDWARDS, B. K., & CASSIDY, J. G. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-2-139 · Cited by 128
Fonagy, P., Sleed, M., & Baradon, T. (2016) · Infant Mental Health Journal · doi:10.1002/imhj.21553 · Cited by 124
Jobes, D. A., Comtois, K. A., Gutierrez, P. M., Brenner, L. A., Huh, D., Chalker, S. A., Ruhe, G., Kerbrat, A. H., Atkins, D. C., Jennings, K., et al. (2017) · Psychiatry · doi:10.1080/00332747.2017.1354607 · Cited by 113
Randomization by minimization for unbalanced treatment allocation
Han, B., Enas, N. H., & McEntegart, D. (2009) · Statistics in Medicine · doi:10.1002/sim.3710 · Cited by 112
Hees, H. L., de Vries, G., Koeter, M. W. J., & Schene, A. H. (2013) · Occupational and Environmental Medicine · doi:10.1136/oemed-2012-100789 · Cited by 116
Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer
Clark, M. M., Rummans, T. A., Atherton, P. J., Cheville, A. L., Johnson, M. E., Frost, M. H., Miller, J. J., Sloan, J. A., Graszer, K. M., Haas, J. G., et al. (2013) · Cancer · doi:10.1002/cncr.27776 · Cited by 115
Davies, A., Merli, F., Mihaljevic, B., Siritanaratkul, N., Solal-Céligny, P., Barrett, M., Berge, C., Bittner, B., Boehnke, A., McIntyre, C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70005-1 · Cited by 114
Gelin, J., Jivegård, L., Taft, C., Karlsson, J., Sullivan, M., Dahllöf, A.-G., Sandström, R., Arfvidsson, B., & Lundholm, K. (2001) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2001.1413 · Cited by 114
Kearney, R. S., Ji, C., Warwick, J., Parsons, N., Brown, J., Harrison, P., Young, J., Costa, M. L., Collaborators, A. T., Dasari, K., et al. (2021) · JAMA · doi:10.1001/jama.2021.6986 · Cited by 113
Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial
The EMPA-KIDNEY Collaborative Group, Herrington, W. G., Wanner, C., Green, J. B., Hauske, S. J., Judge, P., Mayne, K. J., Ng, S. Y. A., Sammons, E., Zhu, D., et al. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac040 · Cited by 110
Czyz, E. K., King, C. A., & Biermann, B. J. (2019) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2018.1496442 · Cited by 105
Nolan, C. M., Maddocks, M., Canavan, J. L., Jones, S. E., Delogu, V., Kaliaraju, D., Banya, W., Kon, S. S. C., Polkey, M. I., & Man, W. D.-C. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1372oc · Cited by 104
Lemieux, P., Weisnagel, S. J., Caron, A. Z., Julien, A.-S., Morisset, A.-S., Carreau, A.-M., Poirier, J., Tchernof, A., Robitaille, J., Bergeron, J., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0156 · Cited by 102
Metadata
- Authors
- Pocock, S. J., & Simon, R.
- Venue
- Biometrics
- Publisher
- JSTOR
- Published
- 1975-03
- Volume
- 31
- Issue
- 1
- Pages
- 103
- ISSN
- 0006-341X (ISSN-L)
- OpenAlex
- W2000366267
- Cited by
- 2,350
- References
- 1
- Citations by year
- 2026: 67 · 2025: 90 · 2024: 84 · 2023: 93 · 2022: 84 · 2021: 94 · 2020: 100 · 2019: 93 · 2018: 95 · 2017: 102 · 2016: 100 · 2015: 82 · 2014: 105 · 2013: 88 · 2012: 119
- FWCI
- 9.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biometrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Social Sciences › Decision Sciences › Management Science and Operations Research › Optimal Experimental Design Methods
- Keywords
- prognostic factors, restricted randomization, stratified randomization, clinical trials
- MeSH terms
- Carmustine, Clinical Trials as Topic, Cyclophosphamide, Evaluation Studies as Topic, Humans, Lymphoma, Models, Theoretical, Prednisone, Prognosis, Statistics as Topic, Vincristine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review